Clinical Trial Results: Sirolimus for Nosebleeds in HHT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for sirolimus in treating nosebleeds associated with hereditary hemorrhagic telangiectasia have been completed, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epistaxis
• Hereditary Hemorrhagic Telangiectasia
• Nosebleeds

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Unity Health Toronto | Conditions: Hereditary Hemorrhagic Telangiectasia, Nosebleeds | Phase 2 | Status: COMPLETED | Results posted: 2026-06-04